Delayed Prostate Cancer Therapy Clifton Park NY

The evidence seems to contradict the assumption that living with untreated prostate cancer is nerve-wracking for most patients, according to Dr. Roderick van den Bergh, of Erasmus Medical Center in Rotterdam, and colleagues.

Local Companies

John Caracandas
(518) 489-0044
400 Patroon Creek Blvd
Albany, NY
STEWART SILVERS, MD
(518) 399-4600
896 Riverview Road
Rexford, NY
SYDNEY WELT, MD
(518) 525-6418
317 S Manning Boulevard
Albany, NY
Nini Choun-Yi Wu, MD
518-489-0044
317 S Manning Blvd Ste 310
Albany, NY
Marek S Poniewierski, MD, MS
518-458-9868
Exec Pike-2 Tower Pl-2nd Fl
Albany, NY
Edward M Liebers
(518) 226-6000
3 Care Ln
Saratoga Springs, NY
KAREN TEDESCO, MD
(518) 843-0020
1700 Riverfront Center
Amsterdam, NY
REGINA RESTA, MD
(518) 272-2097
2200 Burdett Avenue
Troy, NY
Arthur Lewis Sunkin, MD
518-271-3220
3 S Colonial Hts
Troy, NY
Carlos M De Castro, MD
919-684-8964
190 5th Ave
Troy, NY
Data Provided by:
    

Provided By:

MONDAY, July 27 (HealthDay News) -- Men who delay treatment for their early prostate cancer are not especially anxious about living with the disease, new Dutch research shows.

The evidence seems to contradict the assumption that living with untreated prostate cancer is nerve-wracking for most patients, according to Dr. Roderick van den Bergh, of Erasmus Medical Center in Rotterdam, and colleagues. The findings are published in the Sept. 1 issue of Cancer.

The researchers surveyed 129 men regarding their levels of depression and anxiety over their treatment decision. More than 80 percent scored favorably low and compared well emotionally with patients who had opted for more aggressive treatment, the study found.

Men who were in poor general health and those with neurotic personalities expressed higher levels of anxiety and distress, suggesting that factors other than cancer may impact a patient's emotional response, the researchers noted.

The study is especially useful in an era when prostate-specific antigen tests and other screening exams are uncovering prostate cancer at increasingly earlier stages. Many physicians practice a "wait-and-see" approach to treatment, saving the more aggressive therapies for when the cancer grows or spreads, according to information in a news release from the American Cancer Society.

Nationally, prostate cancer is one of the most common cancers and is expected to strike more than 190,000 men this year, and result in over 27,000 deaths, according to the American Cancer Society. But thanks to more effective screenings and treatments, while one in six U.S. men will develop prostate cancer during their lifetime, only one in 35 will actually die of the disease. What's more, there are more than 2 million men in the United States who have been diagnosed with prostate cancer at some point and are still alive today, according to the society.

More information

The U.S. National Cancer Institute has more on prostate cancer.

SOURCE: American Cancer Society, news release, July 27, 2009

Copyright © 2009 ScoutNews, LLC. All rights reserved.

Read Article at HealthDay.com

Related Articles
- Hormone Therapy for Prostate Cancer Clifton Park NY
Hormone therapy to treat advanced prostate cancer can increase the risk of heart disease, but some types of hormone therapy appear to be safer than others, new research has found. The study included 30,642 Swedish men with either locally advanced prostate cancer or prostate cancer that had spread (metastatic cancer), who had received hormone therapy as primary treatment for their cancer.
- Attack Of The Cancer Fighting Tomatoes Clifton Park NY
- Drug Combo Proves Powerful Against Lung Cancer Clifton Park NY
- Hormone Therapy for Early Prostate Cancer Clifton Park NY
- Head and Neck Cancer Treatment Clifton Park NY
- Hormone Therapy for Breast Cancer Clifton Park NY
- Hormone Therapy for Lung Cancer Clifton Park NY
- Exercise for Prostate Cancer Clifton Park NY
- Open Prostatectomy Versus Laparoscopic Procedure Clifton Park NY
- Diagnosis of Prostate Cancer Clifton Park NY